Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: @lambertsluncatic: Why is it

one thing is clear! they the bod their attorney and financier are not sharing any insight with ptsc shareholders.

coming soon maybe 20 shares for a dollar who will benefit from this history repeated, perhaps reverse split 10 shares for 1, makes a beautiful base to release another 400 million. we just do not know but trusting these individuals to make decisions for shareholder benefit have been slim. time to put these individuals to credibility

Share
New Message
Please login to post a reply